RCUS
Price
$9.22
Change
+$0.29 (+3.25%)
Updated
Jun 2 closing price
Capitalization
976.26M
58 days until earnings call
TRDA
Price
$8.14
Change
+$0.54 (+7.11%)
Updated
Jun 2 closing price
Capitalization
308.94M
64 days until earnings call
Interact to see
Advertisement

RCUS vs TRDA

Header iconRCUS vs TRDA Comparison
Open Charts RCUS vs TRDABanner chart's image
Arcus Biosciences
Price$9.22
Change+$0.29 (+3.25%)
Volume$1.48M
Capitalization976.26M
Entrada Therapeutics
Price$8.14
Change+$0.54 (+7.11%)
Volume$203.02K
Capitalization308.94M
RCUS vs TRDA Comparison Chart
Loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCUS vs. TRDA commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a StrongBuy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (RCUS: $9.22 vs. TRDA: $8.14)
Brand notoriety: RCUS and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 105% vs. TRDA: 126%
Market capitalization -- RCUS: $976.26M vs. TRDA: $308.94M
RCUS [@Biotechnology] is valued at $976.26M. TRDA’s [@Biotechnology] market capitalization is $308.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • RCUS’s TA Score: 5 bullish, 3 bearish.
  • TRDA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than RCUS.

Price Growth

RCUS (@Biotechnology) experienced а +2.22% price change this week, while TRDA (@Biotechnology) price change was +8.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was +1.10%, and the average quarterly price growth was -0.30%.

Reported Earning Dates

RCUS is expected to report earnings on Jul 31, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($976M) has a higher market cap than TRDA($309M). RCUS YTD gains are higher at: -38.079 vs. TRDA (-52.921). TRDA has higher annual earnings (EBITDA): 7.89M vs. RCUS (-377M). RCUS has more cash in the bank: 997M vs. TRDA (383M). TRDA has less debt than RCUS: TRDA (57M) vs RCUS (60M). TRDA has higher revenues than RCUS: TRDA (172M) vs RCUS (141M).
RCUSTRDARCUS / TRDA
Capitalization976M309M316%
EBITDA-377M7.89M-4,776%
Gain YTD-38.079-52.92172%
P/E RatioN/A13.10-
Revenue141M172M82%
Total Cash997M383M260%
Total Debt60M57M105%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RCUSTRDA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 21 days ago
83%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADNRX15.750.24
+1.55%
American Beacon ARK Transfmt Innov R6
GATCX40.30N/A
N/A
Gabelli Asset C
FAPMX12.99N/A
N/A
Fidelity Advisor Healthy Future I
ARAQX10.39N/A
N/A
Aristotle Value Eq A
OAZBX36.16-0.08
-0.22%
Oakmark Equity and Income R6

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with ACLX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+3.25%
ACLX - RCUS
48%
Loosely correlated
-0.21%
XNCR - RCUS
47%
Loosely correlated
+7.25%
APGE - RCUS
47%
Loosely correlated
-0.85%
IMNM - RCUS
46%
Loosely correlated
+3.42%
TRDA - RCUS
46%
Loosely correlated
+7.11%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+7.11%
CRNX - TRDA
55%
Loosely correlated
+4.49%
ATXS - TRDA
54%
Loosely correlated
+0.42%
RXRX - TRDA
53%
Loosely correlated
+4.55%
IMNM - TRDA
52%
Loosely correlated
+3.42%
BEAM - TRDA
52%
Loosely correlated
+2.27%
More